News & Updates

Treatment with semaglutide yields early and sustained improvements in multiple atherosclerotic cardiovascular disease (ASCVD) factors in high-risk patients with type 2 diabetes (T2D) and ASCVD and/or chronic kidney disease (CKD), according to a post hoc analysis of the SOUL trial.

Results from the 10-year follow-up of the HOST-EXAM* trial favour clopidogrel over aspirin as chronic maintenance therapy after percutaneous coronary intervention (PCI) with a drug-eluting stent (DES).

The conicity index (C-index) appears to be the most robust and most consistent prognostic value among adiposity indices in anticoagulated patients with atrial fibrillation (AF), suggests a study.

Researchers from the University of Hong Kong (HKU) have developed an innovative AI-based tool that can predict, with enhanced accuracy, the risk of six most common cardiovascular diseases (CVDs) up to 15 years prior to disease onset when combined with clinical data.

For adults with hypertension, maintaining a healthy lifestyle may help prevent the development of major cardiometabolic disease regardless of antihypertensive medication use, as shown in a study.

The uptake and optimization of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF) remain poor in Singapore, owing to underprescription, inadequate dosing, and medication discontinuation, according to a retrospective study.